Chimeric antigen receptor-based cell therapy for treating urological tumors
{{output}}
Urological tumors represent a significant global health challenge, with conventional therapies often proving insufficient to control disease progression. Recent breakthroughs in cellular immunotherapy, particularly in chimeric antigen receptor (CAR)-T cell, CA... ...